XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the target of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 556 shares, a growth of 561.9% from the May 31st total of 84 shares. Based on an average daily trading volume, of 1,420 shares, the days-to-cover ratio is presently 0.4 days.
XOMA Stock Up 0.1%
NASDAQ XOMAP opened at $25.48 on Friday. The firm’s fifty day moving average price is $25.51 and its 200 day moving average price is $26.03. XOMA has a 12 month low of $25.14 and a 12 month high of $30.00.
XOMA Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd will be paid a $0.5391 dividend. This represents a $2.16 annualized dividend and a yield of 8.5%. The ex-dividend date is Thursday, July 2nd.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Recommended Stories
- Five stocks we like better than XOMA
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
